SUBLOCADE™ (buprenorphine extended-release): The first once-monthly buprenorphine injection designed to deliver therapeutic plasma concentrations for the treatment of moderate to severe opioid use disorder (OUD).
This medication is part of the Indivior family of medications such as Suboxone.
Visit Sublocade’s website to learn more